C
Choong Ang Vaccine Laboratory
KOSDAQ:072020
Choong Ang Vaccine Laboratory
KOSDAQ:072020
Price:
9 560
KRW
-1.24%
Market Closed
Market Cap:
₩92.3B
Balance Sheet
Balance Sheet Decomposition
Choong Ang Vaccine Laboratory
Choong Ang Vaccine Laboratory
Balance Sheet Decomposition is not available for
Choong Ang Vaccine Laboratory
Choong Ang Vaccine Laboratory
Balance Sheet
Choong Ang Vaccine Laboratory
Choong Ang Vaccine Laboratory
Currency: KRW
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
86
|
757
|
572
|
460
|
712
|
2 210
|
2 710
|
2 574
|
13 875
|
1 371
|
1 666
|
1 965
|
2 328
|
7 413
|
8 793
|
14 470
|
9 952
|
10 986
|
13 398
|
12 281
|
11 337
|
7 848
|
14 389
|
13 463
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
935
|
0
|
0
|
0
|
7
|
4
|
1
|
3
|
1
|
2
|
1
|
2
|
3
|
4
|
3
|
2
|
|
| Cash Equivalents |
86
|
757
|
572
|
460
|
712
|
2 210
|
2 710
|
2 574
|
12 940
|
1 371
|
1 666
|
1 965
|
2 321
|
7 409
|
8 792
|
14 467
|
9 951
|
10 984
|
13 397
|
12 279
|
11 335
|
7 844
|
14 387
|
13 461
|
|
| Short-Term Investments |
129
|
240
|
4 040
|
1 740
|
1 902
|
1 589
|
6 890
|
9 815
|
778
|
12 315
|
14 813
|
9 244
|
6 307
|
3 647
|
5 098
|
5 621
|
5 069
|
17 300
|
10 927
|
10 486
|
10 131
|
10 138
|
13 035
|
15 690
|
|
| Total Receivables |
1 767
|
988
|
1 264
|
1 365
|
1 563
|
1 954
|
1 488
|
1 844
|
1 436
|
1 992
|
1 459
|
1 570
|
1 695
|
1 473
|
1 338
|
2 030
|
1 461
|
2 758
|
2 404
|
3 410
|
3 442
|
3 401
|
4 502
|
5 183
|
|
| Accounts Receivables |
1 760
|
988
|
1 237
|
1 334
|
1 518
|
1 868
|
1 456
|
1 715
|
1 217
|
1 508
|
1 240
|
1 256
|
1 689
|
1 472
|
1 336
|
2 030
|
1 445
|
2 551
|
2 341
|
2 271
|
3 383
|
3 300
|
4 345
|
5 037
|
|
| Other Receivables |
7
|
0
|
27
|
31
|
45
|
86
|
32
|
129
|
219
|
484
|
219
|
314
|
6
|
1
|
2
|
0
|
16
|
207
|
63
|
1 139
|
60
|
101
|
157
|
146
|
|
| Inventory |
1 473
|
1 654
|
2 089
|
2 433
|
2 616
|
2 598
|
2 387
|
3 363
|
3 549
|
3 656
|
4 503
|
6 303
|
13 037
|
14 035
|
13 257
|
14 027
|
16 676
|
16 145
|
15 471
|
15 923
|
14 613
|
17 918
|
18 464
|
17 690
|
|
| Other Current Assets |
28
|
15
|
205
|
230
|
455
|
99
|
211
|
144
|
260
|
219
|
251
|
189
|
202
|
180
|
212
|
211
|
209
|
140
|
149
|
241
|
320
|
284
|
171
|
424
|
|
| Total Current Assets |
3 482
|
3 653
|
8 170
|
6 228
|
7 247
|
8 451
|
13 687
|
17 740
|
19 899
|
19 553
|
22 692
|
19 271
|
23 569
|
26 747
|
28 698
|
36 359
|
33 366
|
47 329
|
42 350
|
42 342
|
39 844
|
39 590
|
50 561
|
52 450
|
|
| PP&E Net |
5 110
|
5 057
|
6 193
|
7 827
|
7 549
|
7 555
|
9 249
|
10 381
|
13 713
|
18 011
|
17 426
|
29 174
|
30 624
|
30 933
|
30 054
|
33 926
|
44 594
|
45 724
|
47 344
|
57 891
|
66 091
|
66 969
|
63 272
|
64 421
|
|
| PP&E Gross |
5 110
|
5 057
|
6 193
|
7 827
|
7 549
|
7 555
|
9 249
|
10 381
|
13 713
|
18 011
|
17 426
|
29 174
|
30 624
|
30 933
|
30 054
|
33 926
|
44 594
|
45 724
|
47 344
|
57 891
|
66 091
|
66 969
|
63 272
|
64 421
|
|
| Accumulated Depreciation |
2 656
|
3 033
|
3 504
|
4 039
|
4 649
|
5 278
|
4 712
|
5 307
|
5 976
|
6 553
|
7 916
|
9 461
|
12 396
|
15 052
|
18 474
|
21 281
|
23 464
|
27 156
|
28 328
|
31 636
|
30 123
|
35 759
|
40 722
|
45 796
|
|
| Intangible Assets |
97
|
49
|
153
|
274
|
388
|
527
|
564
|
926
|
1 171
|
1 244
|
1 112
|
824
|
1 130
|
1 292
|
1 285
|
1 069
|
951
|
998
|
774
|
446
|
325
|
439
|
533
|
1 064
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
48
|
32
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
299
|
299
|
334
|
332
|
325
|
600
|
1 667
|
1 392
|
510
|
550
|
413
|
623
|
593
|
573
|
890
|
1 075
|
1 365
|
865
|
4 720
|
3 403
|
4 036
|
4 411
|
2 976
|
3 672
|
|
| Other Long-Term Assets |
177
|
163
|
260
|
362
|
327
|
633
|
660
|
617
|
735
|
815
|
765
|
926
|
1 114
|
1 054
|
1 175
|
1 113
|
1 347
|
1 828
|
1 332
|
866
|
2 656
|
3 450
|
2 251
|
1 668
|
|
| Total Assets |
9 164
N/A
|
9 222
+1%
|
15 110
+64%
|
15 024
-1%
|
15 835
+5%
|
17 765
+12%
|
25 829
+45%
|
31 055
+20%
|
36 028
+16%
|
40 172
+12%
|
42 408
+6%
|
50 817
+20%
|
57 031
+12%
|
60 599
+6%
|
62 103
+2%
|
73 543
+18%
|
81 624
+11%
|
96 744
+19%
|
96 567
0%
|
104 979
+9%
|
112 952
+8%
|
114 859
+2%
|
119 593
+4%
|
123 275
+3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
152
|
11
|
549
|
423
|
388
|
213
|
453
|
578
|
506
|
1 017
|
182
|
189
|
1 536
|
1 197
|
2 436
|
1 913
|
965
|
668
|
526
|
443
|
607
|
443
|
307
|
793
|
|
| Accrued Liabilities |
230
|
174
|
166
|
257
|
183
|
250
|
524
|
564
|
990
|
429
|
658
|
535
|
901
|
958
|
1 643
|
1 498
|
1 374
|
1 694
|
1 630
|
2 834
|
2 307
|
2 199
|
3 289
|
3 581
|
|
| Short-Term Debt |
500
|
0
|
0
|
0
|
100
|
0
|
0
|
0
|
135
|
123
|
175
|
159
|
0
|
3 100
|
400
|
3 091
|
3 100
|
3 000
|
1 650
|
5 407
|
6 429
|
6 429
|
4 095
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 000
|
2 649
|
0
|
0
|
0
|
0
|
0
|
162
|
122
|
121
|
141
|
159
|
1 852
|
|
| Other Current Liabilities |
1 086
|
779
|
510
|
342
|
325
|
743
|
66
|
509
|
127
|
207
|
915
|
2 922
|
2 754
|
2 332
|
2 017
|
2 627
|
5 759
|
3 491
|
3 390
|
3 648
|
4 897
|
4 101
|
4 803
|
5 786
|
|
| Total Current Liabilities |
1 968
|
964
|
1 225
|
1 022
|
996
|
1 205
|
1 043
|
1 651
|
1 759
|
1 776
|
1 930
|
4 805
|
7 840
|
7 587
|
6 496
|
9 129
|
11 198
|
8 853
|
7 359
|
12 454
|
14 361
|
13 313
|
12 653
|
12 012
|
|
| Long-Term Debt |
1 534
|
953
|
975
|
372
|
519
|
78
|
0
|
0
|
0
|
0
|
0
|
1 500
|
500
|
400
|
0
|
3 500
|
5 400
|
2 400
|
2 512
|
4 732
|
5 340
|
5 975
|
6 820
|
7 026
|
|
| Other Liabilities |
304
|
334
|
258
|
248
|
368
|
338
|
236
|
406
|
289
|
218
|
395
|
391
|
568
|
622
|
727
|
548
|
349
|
486
|
329
|
244
|
275
|
267
|
316
|
370
|
|
| Total Liabilities |
3 805
N/A
|
2 251
-41%
|
2 457
+9%
|
1 641
-33%
|
1 882
+15%
|
1 621
-14%
|
1 279
-21%
|
2 057
+61%
|
2 048
0%
|
1 994
-3%
|
2 325
+17%
|
6 696
+188%
|
8 908
+33%
|
8 609
-3%
|
7 222
-16%
|
13 177
+82%
|
16 947
+29%
|
11 740
-31%
|
10 200
-13%
|
17 429
+71%
|
19 976
+15%
|
19 554
-2%
|
19 788
+1%
|
19 408
-2%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
3 310
|
2 317
|
3 310
|
3 310
|
3 310
|
3 310
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
3 660
|
4 980
|
4 980
|
4 980
|
4 980
|
4 980
|
4 980
|
4 980
|
|
| Retained Earnings |
1 782
|
3 394
|
4 212
|
4 942
|
5 512
|
7 699
|
11 009
|
15 434
|
20 390
|
24 587
|
26 493
|
30 530
|
34 547
|
38 413
|
41 304
|
46 789
|
51 100
|
54 031
|
55 393
|
57 961
|
64 975
|
68 376
|
68 861
|
74 063
|
|
| Additional Paid In Capital |
267
|
1 260
|
5 131
|
5 131
|
5 131
|
5 131
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
9 916
|
26 022
|
26 023
|
26 023
|
26 023
|
26 023
|
26 023
|
26 023
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
4
|
36
|
12
|
14
|
16
|
14
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
0
|
0
|
0
|
0
|
0
|
1 080
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
1 414
|
3 002
|
4 074
|
60
|
118
|
|
| Total Equity |
5 359
N/A
|
6 971
+30%
|
12 653
+82%
|
13 383
+6%
|
13 953
+4%
|
16 144
+16%
|
24 549
+52%
|
28 998
+18%
|
33 981
+17%
|
38 178
+12%
|
40 083
+5%
|
44 121
+10%
|
48 123
+9%
|
51 989
+8%
|
54 880
+6%
|
60 365
+10%
|
64 676
+7%
|
85 004
+31%
|
86 367
+2%
|
87 550
+1%
|
92 976
+6%
|
95 304
+3%
|
99 804
+5%
|
103 867
+4%
|
|
| Total Liabilities & Equity |
9 164
N/A
|
9 222
+1%
|
15 110
+64%
|
15 024
-1%
|
15 835
+5%
|
17 765
+12%
|
25 829
+45%
|
31 055
+20%
|
36 028
+16%
|
40 172
+12%
|
42 408
+6%
|
50 817
+20%
|
57 031
+12%
|
60 599
+6%
|
62 103
+2%
|
73 543
+18%
|
81 624
+11%
|
96 744
+19%
|
96 567
0%
|
104 979
+9%
|
112 952
+8%
|
114 859
+2%
|
119 593
+4%
|
123 275
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
5
|
6
|
8
|
8
|
8
|
8
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
